Most cancer patients would join a clinical trial if offered the chance

Reuters Health - 19/10/2020 - New findings debunk the conventional wisdom that Black cancer patients are less likely to agree to participate in clinical trials. Overall, 55% of patients offered trial participation agreed to enroll, and white and Black patients agreed to participate at a similar rate, Dr. Joseph M. Unger of Fred Hutchinson Cancer Research Center in Seattle and colleagues found. "Patients are much more willing to participate in cancer clinical trials than people generally realize," Dr. Unger told Reuters Health by email. "Importantly, the willingness to participate does not differ by race or ethnicity." Just a small minority of adult cancer patients enroll in clinical trials in the U.S., with reported participation rates ranging from 2% to 8%, Dr. Unger and his colleagues note in the Journal of the National Cancer Institute. In a 2019 study, published in the same journal, they found that more than three-quarters of cancer patients faced structu...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 19 October, 202028 October, 2020